View in EDS HTML Full Text PDF Full Text

First Real-World Data of Olaparib Combination Treatment with Abiraterone and Prednisone or Prednisolone in First-Line Metastatic Castration-Resistant Prostate Cancer (mCRPC): Descriptive Analysis of 154 Patients Enrolled in the Early Access Program in France.

Saved in:
Bibliographic Details
Title: First Real-World Data of Olaparib Combination Treatment with Abiraterone and Prednisone or Prednisolone in First-Line Metastatic Castration-Resistant Prostate Cancer (mCRPC): Descriptive Analysis of 154 Patients Enrolled in the Early Access Program in France.
Authors: Dourthe LM; Clinique Sainte-Anne, Strasbourg, France., Guillot A; Hôpital Privé de la Loire, Saint-Étienne, France., Vassal C; Hôpital Privé de la Loire, Saint-Étienne, France., Kazan E; Hôpital Privé La Louvière, Lille, France., Coeffic D; Hôpital Privé de Provence, Aix-en-Provence, France., Rebischung C; Médipôle de Savoie, Challes-les-Eaux, France., Suau D; AstraZeneca, 31 Place des Corolles, 92400, Courbevoie, France., Lahouegue A; AstraZeneca, 31 Place des Corolles, 92400, Courbevoie, France., Aboulabbes S; AstraZeneca, 31 Place des Corolles, 92400, Courbevoie, France., Falabrègues A; AstraZeneca, 31 Place des Corolles, 92400, Courbevoie, France. amelie.falabregues@astrazeneca.com., Ould Lahsen H; AstraZeneca, 31 Place des Corolles, 92400, Courbevoie, France.
Source: Drugs - real world outcomes [Drugs Real World Outcomes] 2026 Jun; Vol. 13 (2), pp. 211-224. Date of Electronic Publication: 2026 Apr 13.
Publication Type: Journal Article
Journal Info: Publisher: Springer International Publishing Country of Publication: Switzerland NLM ID: 101658456 Publication Model: Print-Electronic Cited Medium: Print ISSN: 2199-1154 (Print) Linking ISSN: 21989788 NLM ISO Abbreviation: Drugs Real World Outcomes Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 41973335
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: First Real-World Data of Olaparib Combination Treatment with Abiraterone and Prednisone or Prednisolone in First-Line Metastatic Castration-Resistant Prostate Cancer (mCRPC): Descriptive Analysis of 154 Patients Enrolled in the Early Access Program in France.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Dourthe+LM%22">Dourthe LM</searchLink>; Clinique Sainte-Anne, Strasbourg, France.<br /><searchLink fieldCode="AU" term="%22Guillot+A%22">Guillot A</searchLink>; Hôpital Privé de la Loire, Saint-Étienne, France.<br /><searchLink fieldCode="AU" term="%22Vassal+C%22">Vassal C</searchLink>; Hôpital Privé de la Loire, Saint-Étienne, France.<br /><searchLink fieldCode="AU" term="%22Kazan+E%22">Kazan E</searchLink>; Hôpital Privé La Louvière, Lille, France.<br /><searchLink fieldCode="AU" term="%22Coeffic+D%22">Coeffic D</searchLink>; Hôpital Privé de Provence, Aix-en-Provence, France.<br /><searchLink fieldCode="AU" term="%22Rebischung+C%22">Rebischung C</searchLink>; Médipôle de Savoie, Challes-les-Eaux, France.<br /><searchLink fieldCode="AU" term="%22Suau+D%22">Suau D</searchLink>; AstraZeneca, 31 Place des Corolles, 92400, Courbevoie, France.<br /><searchLink fieldCode="AU" term="%22Lahouegue+A%22">Lahouegue A</searchLink>; AstraZeneca, 31 Place des Corolles, 92400, Courbevoie, France.<br /><searchLink fieldCode="AU" term="%22Aboulabbes+S%22">Aboulabbes S</searchLink>; AstraZeneca, 31 Place des Corolles, 92400, Courbevoie, France.<br /><searchLink fieldCode="AU" term="%22Falabrègues+A%22">Falabrègues A</searchLink>; AstraZeneca, 31 Place des Corolles, 92400, Courbevoie, France. amelie.falabregues@astrazeneca.com.<br /><searchLink fieldCode="AU" term="%22Ould+Lahsen+H%22">Ould Lahsen H</searchLink>; AstraZeneca, 31 Place des Corolles, 92400, Courbevoie, France.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101658456%22">Drugs - real world outcomes</searchLink> [Drugs Real World Outcomes] 2026 Jun; Vol. 13 (2), pp. 211-224. <i>Date of Electronic Publication: </i>2026 Apr 13.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Springer+International+Publishing%22">Springer International Publishing </searchLink><i>Country of Publication: </i>Switzerland <i>NLM ID: </i>101658456 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Print <i>ISSN: </i>2199-1154 (Print) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2221989788%22">21989788 </searchLink><i>NLM ISO Abbreviation: </i>Drugs Real World Outcomes <i>Subsets: </i>PubMed not MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=41973335
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1007/s40801-026-00551-z
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 211
    Titles:
      – TitleFull: First Real-World Data of Olaparib Combination Treatment with Abiraterone and Prednisone or Prednisolone in First-Line Metastatic Castration-Resistant Prostate Cancer (mCRPC): Descriptive Analysis of 154 Patients Enrolled in the Early Access Program in France.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Dourthe LM
      – PersonEntity:
          Name:
            NameFull: Guillot A
      – PersonEntity:
          Name:
            NameFull: Vassal C
      – PersonEntity:
          Name:
            NameFull: Kazan E
      – PersonEntity:
          Name:
            NameFull: Coeffic D
      – PersonEntity:
          Name:
            NameFull: Rebischung C
      – PersonEntity:
          Name:
            NameFull: Suau D
      – PersonEntity:
          Name:
            NameFull: Lahouegue A
      – PersonEntity:
          Name:
            NameFull: Aboulabbes S
      – PersonEntity:
          Name:
            NameFull: Falabrègues A
      – PersonEntity:
          Name:
            NameFull: Ould Lahsen H
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 06
              Text: 2026 Jun
              Type: published
              Y: 2026
          Identifiers:
            – Type: issn-print
              Value: 2199-1154
          Numbering:
            – Type: volume
              Value: 13
            – Type: issue
              Value: 2
          Titles:
            – TitleFull: Drugs - real world outcomes
              Type: main
ResultId 1